There are a growing number of people experiencing lasting effects from COVID-19 including fatigue, shortness of breath, brain fog, anxiety, and depression. As a practitioner, I have witnessed this first-hand. Two patients that come to mind had no previous history of anxiety issues but experienced significant anxiety for months following SARS-CoV2 infection.  I have seen shortness of breath and fatigue persist in relatively young, healthy patients.  There is no definitive consensus of what causes long haulers syndrome although it is likely a combination of excessive inflammation and an exaggerated immune response.  

NAD+ (nicotinamide adenine dinucleotide) is a co-factor that occurs naturally in every cell of the human body and is important to mitochondrial function, our “energy powerhouses”.  Boosting NAD+ is known to improve cellular repair and energy and thus improve mental clarity, alertness, concentration, and memory.  NAD+ declines with age and with stressors on the body such as chronic lack of sleep and excessive alcohol use.  Obesity and type 2 diabetes are also associated with decreased NAD+ levels as well as chronic low-grade inflammation.  Studies may show that SARS-CoV-2 directly impairs mitochondrial energy metabolism by decreasing oxygen availability to the cells which in turn decreases intracellular energy production.   This is where NAD+ may be beneficial in treating acute and long term COVID-19 symptoms.    Replenishing NAD+ may reduce the hyperinflammation that some patients develop which is a major source of complications with COVID-19.

At Alpine Health & Wellness we offer NAD+ infusions in a comfortable, respectful clinic setting.  Typically, several infusions are recommended for optimal benefits. If you are one of the many people experiencing persistent COVID-19 symptoms, call today to schedule your first infusion to begin your road to recovery. 

Sources:

Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity – PubMed (nih.gov)

COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity (nih.gov)

Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: A hypothesis – PubMed (nih.gov)

Add Comment

Your email address will not be published. Required fields are marked *